Table 1.
Variables patients, n | Total cohort (n = 199) |
---|---|
Mean age (years)a | 55 ± 7.99 |
Gender (Males/Females) | 160/39 |
Patients (HBV/HCV/other) | 146/10/43 |
Median level of serum AFP (ng/ml) | 39.6 |
Cirrhosis (presence/absence) | 97/102 |
Tumor stage (T1/T2/T3)b | 82/84/33 |
Vascular invasion (yes/no) | 116/83 |
Major portal vein invasion (yes/no) | 19/180 |
Intrahepatic invasion (yes/no) | 33/166 |
Recurrence (yes/no) | 120/79 |
AJCC TNM staging for HCC; T1, solitary tumor without vascular invasion; T2, solitary tumor with vascular invasion or multiple tumors; T3, multiple tumors or tumors involving a major branch of the portal or hepatic vein.
aMean ± standard deviation; bT1, T2, and T3 grades were judged using the AJCC6th standard.